US regulator has added a warning about rare heart inflammation to Pfizer, Moderna Covid-19 vaccines. Read on to know more.
The arthritis drug developed by Pfizer was associated with 63 per cent lower risk of death or respiratory failure in hospitalised adult patients with Covid-19 pneumonia.
The Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
In an attempt to stop the COVID-19 infection from affecting the children, the UK approved Pfizer/BioNTech Covid-19 vaccine for children aged between 12 and 15 years old.
A BMJ study has found that extending the gap between the first and the second dose of the Covid vaccine may cut down death risk in infected patients.
FDA has approved the Pfizer-BioNTech Covid-19 vaccine for use in adolescents aged 12-16. Here's what you need to know.
After safety reports from trials, the FDA allows the emergency use of Pfizer-BioNTech COVID-19 vaccine in adolescents. Read on to know more.
Pfizer-BioNTech COVID-19 Vaccines Highly Effective Against Variants, Studies Find
A fully vaccinated man died of COVID-19 in Chicago. How long does it take to develop complete immunity after the second vaccine dose? Read to know everything.
Unlike injectables, a hospital environment would not be required for receiving the oral drug as you could get it at home, said Pfizer CEO Albert Bourla.
A whopping 57.2 per cent and 50.9 per cent reported tenderness after the first and second dose of Pfizer vaccine, and 49.3 per cent after the first dose of AstraZeneca vaccine, the researchers said.
A Sputnik V study has claimed that there are more post-vaccination deaths from Pfizer COVID-19 vaccines than from AstraZeneca shots. Read on to know more.
Amid a sudden surge of coronavirus cases, the vaccine-making company Pfizer has said that their vaccine is 100% effective for adolescents. But before getting the jab -- check out who all should avoid taking the jab
Pfizer has started Phase 1 clinical trial of a novel oral antiviral drug for treatment of COVID-19. Meanwhile, Hong Kong and Macau on Wednesday suspended the use of Pfizer/BioNTech's COVID-19 vaccine after defective bottle lids were found in one batch of vials.
As newer strains of the COVID-19 virus emerge, vaccine makers are preparing for the possibility that their shots will not work against the variants.
Most COVID-19 vaccines currently in use work with two shots or doses. Experts believe that availability of single-shot vaccines may help speed up the vaccination process.
Experts also say that Oxford-AstraZeneca vaccine work better if a gap of up to a three-month is kept between the two required doses. In India, the second dose of the vaccine is administered between four and six weeks after the first dose.
A recent study has revealed that a single dose of Pfizer/BioNTech's COVID-19 vaccine is effective in stopping the transmission risk of the novel coronavirus.
A new study says that people who were previously infected with the COVID-19 virus responded very strongly to just one dose of the Pfizer vaccine.
The statement came after Pfizer said that it has decided to withdraw its application for emergency use authorisation of its COVID-19 vaccine in India.
Pfizer was the first pharmaceutical firm to seek an emergency use authorization from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in India.
There is increasing concerns over the seemingly lower efficacy of some approved vaccines towards the new COVID-19 variants. Some immunologists say that the effectiveness of current vaccines will decrease as the coronavirus mutate further in the future.
Most of the vaccines being rolled out around the world train the body to recognize that spike protein and fight it.
Nearly 4,400 adverse events were reported after people received the Pfizer-BioNTech Covid-19 vaccine in the US, with 21 cases determined to be anaphylaxis, according to CDC.
The arthritis drug developed by Pfizer was associated with 63 per cent lower risk of death or respiratory failure in hospitalised adult patients with Covid-19 pneumonia.
The Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
In an attempt to stop the COVID-19 infection from affecting the children, the UK approved Pfizer/BioNTech Covid-19 vaccine for children aged between 12 and 15 years old.
A BMJ study has found that extending the gap between the first and the second dose of the Covid vaccine may cut down death risk in infected patients.
FDA has approved the Pfizer-BioNTech Covid-19 vaccine for use in adolescents aged 12-16. Here's what you need to know.
After safety reports from trials, the FDA allows the emergency use of Pfizer-BioNTech COVID-19 vaccine in adolescents. Read on to know more.
Pfizer-BioNTech COVID-19 Vaccines Highly Effective Against Variants, Studies Find
A fully vaccinated man died of COVID-19 in Chicago. How long does it take to develop complete immunity after the second vaccine dose? Read to know everything.
Unlike injectables, a hospital environment would not be required for receiving the oral drug as you could get it at home, said Pfizer CEO Albert Bourla.
A whopping 57.2 per cent and 50.9 per cent reported tenderness after the first and second dose of Pfizer vaccine, and 49.3 per cent after the first dose of AstraZeneca vaccine, the researchers said.
A Sputnik V study has claimed that there are more post-vaccination deaths from Pfizer COVID-19 vaccines than from AstraZeneca shots. Read on to know more.
Amid a sudden surge of coronavirus cases, the vaccine-making company Pfizer has said that their vaccine is 100% effective for adolescents. But before getting the jab -- check out who all should avoid taking the jab
Pfizer has started Phase 1 clinical trial of a novel oral antiviral drug for treatment of COVID-19. Meanwhile, Hong Kong and Macau on Wednesday suspended the use of Pfizer/BioNTech's COVID-19 vaccine after defective bottle lids were found in one batch of vials.
As newer strains of the COVID-19 virus emerge, vaccine makers are preparing for the possibility that their shots will not work against the variants.
Most COVID-19 vaccines currently in use work with two shots or doses. Experts believe that availability of single-shot vaccines may help speed up the vaccination process.
Experts also say that Oxford-AstraZeneca vaccine work better if a gap of up to a three-month is kept between the two required doses. In India, the second dose of the vaccine is administered between four and six weeks after the first dose.
A recent study has revealed that a single dose of Pfizer/BioNTech's COVID-19 vaccine is effective in stopping the transmission risk of the novel coronavirus.
A new study says that people who were previously infected with the COVID-19 virus responded very strongly to just one dose of the Pfizer vaccine.
The statement came after Pfizer said that it has decided to withdraw its application for emergency use authorisation of its COVID-19 vaccine in India.
Pfizer was the first pharmaceutical firm to seek an emergency use authorization from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in India.
There is increasing concerns over the seemingly lower efficacy of some approved vaccines towards the new COVID-19 variants. Some immunologists say that the effectiveness of current vaccines will decrease as the coronavirus mutate further in the future.
Most of the vaccines being rolled out around the world train the body to recognize that spike protein and fight it.
Nearly 4,400 adverse events were reported after people received the Pfizer-BioNTech Covid-19 vaccine in the US, with 21 cases determined to be anaphylaxis, according to CDC.
A health worker in Portugal died two days after getting the COVID-19 vaccine. This comes as a shock to the world community and has raised questions over the safety and efficiency of the Pfizer vaccine.
